Norges Bank bought a new position in shares of Aflac Incorporated (NYSE:AFL – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm bought 2,397,817 shares of the financial services provider’s stock, valued at approximately $197,820,000.
Several other institutional investors have also recently added to or reduced their stakes in AFL. Fortitude Family Office LLC acquired a new position in Aflac in the fourth quarter worth $25,000. Bruce G. Allen Investments LLC bought a new position in shares of Aflac in the fourth quarter valued at about $32,000. Harvest Fund Management Co. Ltd acquired a new position in Aflac during the 3rd quarter worth about $33,000. Criterion Capital Advisors LLC bought a new stake in Aflac during the 4th quarter worth about $33,000. Finally, Arlington Trust Co LLC acquired a new stake in Aflac in the 4th quarter valued at about $35,000. 67.44% of the stock is owned by institutional investors.
Aflac Stock Performance
AFL stock opened at $87.67 on Thursday. Aflac Incorporated has a 1-year low of $64.10 and a 1-year high of $88.59. The business’s 50-day moving average price is $84.44 and its two-hundred day moving average price is $82.60. The firm has a market cap of $49.82 billion, a PE ratio of 9.68, a P/E/G ratio of 2.39 and a beta of 0.91. The company has a current ratio of 0.08, a quick ratio of 0.08 and a debt-to-equity ratio of 0.34.
Aflac Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 3rd. Investors of record on Wednesday, May 22nd will be given a $0.50 dividend. This is a boost from Aflac’s previous quarterly dividend of $0.42. This represents a $2.00 annualized dividend and a yield of 2.28%. The ex-dividend date is Tuesday, May 21st. Aflac’s payout ratio is currently 22.08%.
Analysts Set New Price Targets
Several research firms have recently commented on AFL. Wells Fargo & Company increased their price target on shares of Aflac from $81.00 to $82.00 and gave the company an “equal weight” rating in a research note on Friday, May 10th. Piper Sandler lifted their target price on Aflac from $90.00 to $95.00 and gave the company an “overweight” rating in a research note on Friday, April 5th. Raymond James upped their price target on Aflac from $83.00 to $88.00 and gave the company an “outperform” rating in a research note on Friday, February 2nd. Morgan Stanley lifted their price objective on Aflac from $80.00 to $84.00 and gave the stock an “equal weight” rating in a research report on Monday, April 15th. Finally, Truist Financial raised their target price on shares of Aflac from $80.00 to $82.00 and gave the company a “hold” rating in a research note on Friday, May 3rd. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $82.38.
Get Our Latest Research Report on Aflac
Insider Buying and Selling
In other news, SVP Albert Riggieri sold 8,000 shares of the business’s stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $83.34, for a total value of $666,720.00. Following the sale, the senior vice president now directly owns 32,825 shares in the company, valued at $2,735,635.50. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, SVP Albert Riggieri sold 8,000 shares of the business’s stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $83.34, for a total value of $666,720.00. Following the sale, the senior vice president now owns 32,825 shares of the company’s stock, valued at $2,735,635.50. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Joseph L. Moskowitz sold 600 shares of the firm’s stock in a transaction on Wednesday, May 8th. The shares were sold at an average price of $84.84, for a total transaction of $50,904.00. Following the completion of the transaction, the director now directly owns 27,550 shares of the company’s stock, valued at approximately $2,337,342. The disclosure for this sale can be found here. In the last ninety days, insiders sold 13,600 shares of company stock valued at $1,140,724. Company insiders own 0.80% of the company’s stock.
About Aflac
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
See Also
- Five stocks we like better than Aflac
- Buy P&G Now, Before It Sets A New All-Time High
- PDD Holdings Earnings Volatility Alerts Buyers
- Why Are Stock Sectors Important to Successful Investing?
- NVIDIA’s Rally is Far From Over, Neither is Volatility
- Business Services Stocks Investing
- Global-e Online is a Must-Own eCommerce Stock
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.